Abstract
Influenza is a respiratory contagious disease infecting people all around the globe. The Center for Disease Control and Prevention had estimated that from 1 October 2018 to 4 May 2019, there have been about 40 million flu patients, in which about 50 thousand cases have died. Many subtypes of influenza have developed drug resistance due to high mutation rates. Neuraminidase (NA) is the glycoprotein on the virus particle surface. Its function is to cleave the glycosidic bond with the sialic acid, leading the new virus to be able to infect other uninfected cells. Therefore, it is a promising protein target for drug design and development. The E276D and R292K NA mutations in the H10N4 influenza virus have been reported to cause drug resistance. In this study, molecular dynamics simulations and free energy calculations were applied to study the source of oseltamivir resistance in E276D, R292K, and E276D/R292K NA strains. The obtained results suggested that all studied mutants reduced the number of contact atoms, interaction energies, H-bonds, per-residue interaction energies, and total binding free energies towards the oseltamivir binding, resulting in a lower susceptibility. Only the interactions at residues 118, 119, and 371 were maintained in stabilizing the oseltamivir. The opening at 150- and 430-loops in E276D and double mutations caused the drug unbinding from the active site, increasing water accessibility into the binding pocket of NA enzyme.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.